Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lackner

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Plos Genetics|August 29, 2009
The fission yeast homeodomain protein Yox1p binds to MBF and confines MBF-dependent cell-cycle transcription to G1-S via negative feedbackSofia Aligianni, Daniel H Lackner, Steffi Klier, et al.
Nucleic Acids Research|November 15, 2007
The BioGRID Interaction Database: 2008 updateBobby-Joe Breitkreutz, Chris Stark, Teresa Reguly, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 22, 2013
Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational studyV Strenger, H Lackner, R Mayer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 15, 2019
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseasesAndreas Trobisch, R Marterer, G Gorkiewicz, et al.
Medical and Pediatric Oncology|June 1, 1997
CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working GroupH Hertzberg, W J Huk, M A Ueberall, et al.
Nature Communications|December 18, 2015
A generic strategy for CRISPR-Cas9-mediated gene taggingDaniel H Lackner, Alexia Carré, Paloma M Guzzardo, et al.
Klinische Padiatrie|November 13, 2012
Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save livesD Sperl, M Benesch, C Urban, et al.
Medical and Pediatric Oncology|January 29, 2002
ELTEC: ten years of activity (1990-2000)--a report of the International BFM Study GroupM Jankovic, A Reciputo, R Haupt, et al.
Pediatric Blood & Cancer|August 13, 2017
Chilblain lupus and steroid-responsive pancytopenia precede monosomy 7-linked AML as manifestation of rasopathyD S Klobassa, M N Dworzak, S Lanz, et al.
Seminars in Hematology|June 18, 2016
Management of chronic immune thrombocytopenia in children and adolescents: lessons from an Austrian national cross-sectional study of 81 patientsJ Sipurzynski, B Fahrner, R Kerbl, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Plos Genetics|August 29, 2009
The fission yeast homeodomain protein Yox1p binds to MBF and confines MBF-dependent cell-cycle transcription to G1-S via negative feedbackSofia Aligianni, Daniel H Lackner, Steffi Klier, et al.
Nucleic Acids Research|November 15, 2007
The BioGRID Interaction Database: 2008 updateBobby-Joe Breitkreutz, Chris Stark, Teresa Reguly, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 22, 2013
Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational studyV Strenger, H Lackner, R Mayer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 15, 2019
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseasesAndreas Trobisch, R Marterer, G Gorkiewicz, et al.
Medical and Pediatric Oncology|June 1, 1997
CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working GroupH Hertzberg, W J Huk, M A Ueberall, et al.
Nature Communications|December 18, 2015
A generic strategy for CRISPR-Cas9-mediated gene taggingDaniel H Lackner, Alexia Carré, Paloma M Guzzardo, et al.
Klinische Padiatrie|November 13, 2012
Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save livesD Sperl, M Benesch, C Urban, et al.
Medical and Pediatric Oncology|January 29, 2002
ELTEC: ten years of activity (1990-2000)--a report of the International BFM Study GroupM Jankovic, A Reciputo, R Haupt, et al.
Pediatric Blood & Cancer|August 13, 2017
Chilblain lupus and steroid-responsive pancytopenia precede monosomy 7-linked AML as manifestation of rasopathyD S Klobassa, M N Dworzak, S Lanz, et al.
Seminars in Hematology|June 18, 2016
Management of chronic immune thrombocytopenia in children and adolescents: lessons from an Austrian national cross-sectional study of 81 patientsJ Sipurzynski, B Fahrner, R Kerbl, et al.
Pageof 16